WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8301 Infant (under 12 months) mortality rate: 522
GDP / capita (US$): 1'7501 Child (under 5 years) mortality rate: 692

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 10'711  10'572  10'431  10'289  10'145  8'549  7'100  5'689 
Births 263  264  264  265  266  266  264  239 
Surviving infants 252  252  252  252  253  249  240  208 
Pop. less than 5 years 1'238  1'241  1'247  1'253  1'254  1'219  1'159  914 
Pop. less than 15 years 3'614  3'611  3'609  3'606  3'600  3'448  3'061  2'337 
Female 15-49 years 2'853  2'807  2'759  2'711  2'662  2'095  1'640  1'368 

Number of reported cases

(Click for retrospective incidence data for Haiti)
Diphtheria
ChartChart
  32  23 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  992  1'414  507 
Mumps
ChartChart
 
Pertussis
ChartChart
  14  913  812 
Polio*
ChartChart
  20 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  13  15  40  143 
Tetanus (total)**
ChartChart
  13  15  143  381 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Haiti)
Vaccine year result method % card seen                                                
BCG 2011  83  DHS   73  72  67  75  74  82  57  72  26 
DTP1 2011  88  DHS   73  79  71  90  99  95 
DTP3 2011  63  DHS   73  72  60  85  85  85  59  41 
DTP4         
IPV1         
HepB_BD         
HepB3          72  60  85 
Hib3          72  60  85 
JapEnc         
MCV1          64  64  80  69  58  80  31 
MCV2         
PCV1         
PCV3         
Pol3 2011  59  DHS   73  76  75  92  80  79  58  40 
Rota1          65  71 
RotaC          55  40 
Rubella1          64  64  80  66  58 
TT2plus 2011  65  DHS   73  50  50  57  59  61  16 
PAB         
VAD1          43  99*  99*  36 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Haiti)
BCG
ChartChart
  81  76  83  83  83  72  72 
DTP1
ChartChart
  80  72  86  87  88  73  66  21 
DTP3
ChartChart
  60  48  68  67  68  41  41 
HepB3
ChartChart
  60  48  68 
HepB_BD
ChartChart
 
Hib3
ChartChart
  60  48  68 
IPV1
ChartChart
 
MCV1
ChartChart
  53  53  65  65  65  55  31 
MCV2
ChartChart
 
PAB
ChartChart
  81  81  76  76  70  41  39  14 
PCV3
ChartChart
 
Pol3
ChartChart
  56  55  67  67  67  50  40 
RCV1
ChartChart
  53  53  65  65  65 
RotaC
ChartChart
  43  23 

Number of districts in the country 140  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 10
From 50 to 79% 42
Less than 50% 26
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Adult >= 12 years; Yes at risk
IPV 6 weeks; Yes
Influenza_Adult >= 65 years; Yes and health care workers and adults with chronic diseases
Influenza_Pediatric 6-24 mois; Yes
MR 9 months; Yes
OPV birth< 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 years; Yes pregnant women
VitaminA 6,12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015    2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 120    105    36    140 

System performance

Total Nº districts in country number 140  140  140  144  141  133  140 
Nº districts with DTP3 coverage >=80% number 45  42  80  68  70  91  62 
% of districts with DTP3 coverage >=80% From 0 to 100% 32  30  57  47  50  68  44 
Nº districts with measles (MCV1) coverage >=95% number 15  13  49  26  21  61 
% of districts with MCV1 coverage >=95% From 0 to 100% 11  35  18  15  46 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%             10 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.